Fluticasone furoate/vilanterol dry-powder inhaler in asthma: a guide to its use in the EU Emma D. DeeksKatherine A. Lyseng-WilliamsonYahiya Y. Syed Adis Drug Q&A 14 March 2017 Pages: 153 - 159
Pixantrone in relapsed or refractory aggressive non-Hodgkin’s lymphoma: a guide to its use Gillian M. KeatingKatherine A. Lyseng-Williamson Adis Drug Q&A 10 March 2017 Pages: 160 - 166
Nivolumab in previously treated patients with advanced renal cell carcinoma: a guide to its use Karly P. Garnock-JonesKatherine A. Lyseng-Williamson Adis Drug Q&A 08 February 2017 Pages: 167 - 173
Laxatives, targeted therapy and lubiprostone are options when individualizing treatment for opioid-induced constipation in the elderly Adis Medical Writers Disease Management 07 March 2017 Pages: 174 - 180
First reports of adverse drug reactions Drug Reactions and Interactions 06 March 2017 Pages: 181 - 182
Overcoming barriers to medication adherence in bipolar disorder: a review of the role of psychosocial and medication-related interventions Adis Medical Writers Practical Issues and Updates 03 February 2017 Pages: 183 - 187
Attitudes and opinions of Portuguese community pharmacy professionals towards patient reporting of adverse drug reactions and the pharmacovigilance system Cristiano MatosL. RodriguesJ. Joaquim Original Research Article 08 February 2017 Pages: 188 - 194